HomeInsights52 Week High Stocks

Procter & Gamble Health Ltd 52 Week High

Procter & Gamble Health Ltd 52 Week High

stocks purchased

₹ 0.1 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

0.2 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 22, 2024

Image

Procter & Gamble Health Ltd

NSE: PGHL

YEARHIGH

₹ 5835.95

Last updated on: Nov 22, 2024

Key Highlights

  • The 52 Week HIGH of Procter & Gamble Health Ltd is ₹ 5835 as of 22 Nov 24 .

Company Fundamentals for Procter & Gamble Health Ltd

No data available

Market Price of Procter & Gamble Health Ltd

1M

1Y

3Y

5Y

Monitoring Procter & Gamble Health Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20245092.55
21 Nov 20245124.1
19 Nov 20245134.95
18 Nov 20245117.4
14 Nov 20245143.95
13 Nov 20245217.4
12 Nov 20245404.55
11 Nov 20245463.35
08 Nov 20245567.55
07 Nov 20245683.85

Asset Value vs Market Value of Procter & Gamble Health Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Procter & Gamble Health Ltd

No data available

* All values are in crore

Historical Net Profit of Procter & Gamble Health Ltd

No data available

* All values are in crore

Procter & Gamble Health Ltd News Hub

News

P&G Health hits 52 week high as Q2 PAT jumps 26% YoY to Rs 82 cr

Profit before tax in Q2 FY25 stood at Rs 111.4 crore, up 26.51% as against Rs 88.05 crore ...

Read more

05 Nov 202409:59

News

Procter & Gamble Health to hold board meeting

Procter & Gamble Health will hold a meeting of the Board of Directors of the Company on 4 ...

Read more

28 Sep 202410:06

News

Procter & Gamble Health schedules AGM

Procter & Gamble Health announced that the 57th Annual General Meeting (AGM) of the compan...

Read more

23 Aug 202411:48

News

P&G Health slides as Q4 PAT drops 44% YoY to Rs 17 cr

Revenue from operations slipped 5.74% year on year to Rs 283.88 crore during the quarter, ...

Read more

22 Aug 202410:02

News

Board of Procter & Gamble Health recommends final dividend

Procter & Gamble Health announced that the Board of Directors of the Company at its meetin...

Read more

21 Aug 202417:54

News

Procter & Gamble Health announces board meeting date

Procter & Gamble Health will hold a meeting of the Board of Directors of the Company on 21...

Read more

28 Jun 202411:17

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Procter & Gamble Health Ltd

What is the significance of Procter & Gamble Health Ltd reaching its 52-week high?

Procter & Gamble Health Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Procter & Gamble Health Ltd 52-week high?

Investors monitor Procter & Gamble Health Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Procter & Gamble Health Ltd a good buy when it hits its 52-week high?

Whether Procter & Gamble Health Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Procter & Gamble Health Ltd fundamentals.

What should I consider before investing in Procter & Gamble Health Ltd at its 52-week high?

Before investing in Procter & Gamble Health Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Procter & Gamble Health Ltd stock price continue to rise after reaching its 52-week high?

Procter & Gamble Health Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*